These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vivo survival of K:18 red cells in a recipient with anti-K18.
    Author: Barrasso C, Baldwin ML, Drew H, Ness PM.
    Journal: Transfusion; 1983; 23(3):258-9. PubMed ID: 6679384.
    Abstract:
    Red cell survival, IgG subclass, and mononuclear phagocyte assay studies were performed on a patient with an anti-K + K18 described previously. The 51Cr survival study with Kell negative K:18 red cells showed 76.6 percent survival at 75 minutes with 30.7 percent survival at 24 hours. The anti-K18 was characterized as IgG4 + IgG1. The mononuclear phagocyte assay was 16 percent when the serum was tested with K:18 cells. Among 54,450 ABO compatible donor units tested with this serum, no K:18- unit was found. These studies were undertaken to evaluate the clinical significance of the antibody when red cell support for a chemotherapy course was considered. Our data suggest that transfusion with K:18+ blood would be ineffective and could be used only to provide red cell support in an emergency should compatible units be unavailable.
    [Abstract] [Full Text] [Related] [New Search]